{"id":"oxynorm","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"20-30","effect":"Nausea"},{"rate":"15-25","effect":"Dizziness"},{"rate":"20-30","effect":"Drowsiness"},{"rate":"10-15","effect":"Vomiting"},{"rate":"5-10","effect":"Pruritus"}]},"_chembl":{"chemblId":"CHEMBL656","moleculeType":"Small molecule","molecularWeight":"315.37"},"_fixedAt":"2026-03-30T18:39:29.986473","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oxycodone is a semi-synthetic opioid agonist that acts primarily on mu (μ) opioid receptors in the brain and spinal cord. The immediate-release formulation allows for quick absorption and onset of analgesia, making it suitable for acute or breakthrough pain management. It works by modulating pain perception and emotional response to pain through central nervous system depression.","oneSentence":"OxyNorm is an immediate-release oral formulation of oxycodone that binds to opioid receptors in the central nervous system to provide rapid pain relief.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:59:24.941Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe acute pain"},{"name":"Breakthrough pain in opioid-tolerant patients"}]},"_fixedFields":["sideEffects","modality→Small Molecule"],"trialDetails":[{"nctId":"NCT05821517","phase":"PHASE4","title":"METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX)","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2023-12-30","conditions":"Anterior Shoulder Dislocation","enrollment":150},{"nctId":"NCT07095569","phase":"NA","title":"Shoulder Denervation for Post Mastectomy Irradiation Shoulder Pain","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute, Egypt","startDate":"2025-08-01","conditions":"Breast Cancer","enrollment":60},{"nctId":"NCT04987372","phase":"PHASE4","title":"Multimodal Versus Opioid aNalgesia in carDiAc Surgery","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2019-01-21","conditions":"Postoperative Pain, Postoperative Delirium","enrollment":100},{"nctId":"NCT05730062","phase":"PHASE1","title":"Influence of Oxycodone on Individuals Taking an SSRI","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2023-03-15","conditions":"Opioid Induced Respiratory Depression, Depressive Disorder, Anxiety Disorders","enrollment":55},{"nctId":"NCT05114265","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults","status":"COMPLETED","sponsor":"Kures, Inc.","startDate":"2022-02-15","conditions":"Acute Pain","enrollment":60},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT02728648","phase":"PHASE4","title":"Population Pharmacokinetic-Pharmacodynamic Study of Intravenous Oxycodone in Malaysian Population","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2016-04","conditions":"Pain","enrollment":33},{"nctId":"NCT03024515","phase":"NA","title":"Opioids Titration Study in Advanced Cancer Patients in Hong Kong","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-08-23","conditions":"Pain Control","enrollment":2},{"nctId":"NCT03011905","phase":"PHASE3","title":"Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2017-01","conditions":"Brachial Plexus Block, Pain, Postoperative","enrollment":53},{"nctId":"NCT04448457","phase":"NA","title":"Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Tivoli","startDate":"2017-09-01","conditions":"Postoperative Pain","enrollment":72},{"nctId":"NCT03176121","phase":"PHASE4","title":"Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-10-31","conditions":"Cancer, Pain","enrollment":73},{"nctId":"NCT03176199","phase":"PHASE4","title":"A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-09-01","conditions":"Cancer, Pain","enrollment":30},{"nctId":"NCT01643772","phase":"PHASE1","title":"OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study","status":"COMPLETED","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2011-05","conditions":"Pain","enrollment":61},{"nctId":"NCT02732262","phase":"PHASE3","title":"Optimal Dose of i.v Oxycodone for Postoperative Pain","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-04","conditions":"Pain","enrollment":134},{"nctId":"NCT03314792","phase":"PHASE4","title":"Effects of Tapentadol Versus Oxycodone After Hysterectomy.","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2017-12-04","conditions":"Pain, Postoperative, Pain Uterus, Pain, Acute","enrollment":86},{"nctId":"NCT02660229","phase":"PHASE4","title":"An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.","status":"COMPLETED","sponsor":"Mundipharma Korea Ltd","startDate":"2015-11","conditions":"Cancer Pain","enrollment":66},{"nctId":"NCT02678897","phase":"PHASE4","title":"Pain and Medical Abortion Among Teenaged Women Compared to Adult Women","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2016-03","conditions":"Pain","enrollment":242},{"nctId":"NCT02094807","phase":"NA","title":"Pain as Indication for Operative Treatment of Traumatic Rib Fractures","status":"WITHDRAWN","sponsor":"Sahlgrenska University Hospital","startDate":"2014-04","conditions":"Trauma, Rib Fractures, Surgery","enrollment":""},{"nctId":"NCT01675635","phase":"PHASE3","title":"OxyNorm Capsules in Post-Operative Pain Study","status":"COMPLETED","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2011-07","conditions":"Postoperative Pain","enrollment":240},{"nctId":"NCT02484352","phase":"PHASE4","title":"Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation","status":"COMPLETED","sponsor":"Yong-Hee Park","startDate":"2015-07","conditions":"Intubation Complication, Blood Pressure","enrollment":95},{"nctId":"NCT03019562","phase":"PHASE4","title":"Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2016-12","conditions":"Pain, Postoperative","enrollment":46},{"nctId":"NCT02840526","phase":"NA","title":"Thoracic Paravertebral Block in Pain Management After Renal Surgery","status":"COMPLETED","sponsor":"Silesian University of Medicine","startDate":"2013-05","conditions":"Postoperative Pain","enrollment":58},{"nctId":"NCT01482936","phase":"PHASE1","title":"Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient","status":"COMPLETED","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2010-05","conditions":"Pain","enrollment":44},{"nctId":"NCT02240602","phase":"PHASE3","title":"Optimal Dose of i.v Oxycodone for Postoperative Pain After Laparoscopic Colorectal Surgery","status":"WITHDRAWN","sponsor":"Seoul National University Hospital","startDate":"2015-07","conditions":"Pain","enrollment":""},{"nctId":"NCT01672112","phase":"PHASE4","title":"Comparison of the Efficacy of Oral Oxycodone and Oral Codeine in the Treatment of Postcraniotomy Pain","status":"COMPLETED","sponsor":"Tan Tock Seng Hospital","startDate":"2012-07","conditions":"Postcraniotomy Pain","enrollment":40},{"nctId":"NCT01816581","phase":"PHASE4","title":"Oral Oxycodone After Major Cardiac Surgery","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-07","conditions":"Heart; Dysfunction Postoperative, Cardiac Surgery","enrollment":50},{"nctId":"NCT00784472","phase":"PHASE3","title":"Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL","status":"COMPLETED","sponsor":"Katja venborg Pedersen","startDate":"2008-12","conditions":"Kidney Stones","enrollment":55},{"nctId":"NCT01303809","phase":"NA","title":"Enhanced Recovery After Laparoscopic Sleeve Gastrectomy - a Randomised Controlled Trial","status":"COMPLETED","sponsor":"University of Auckland, New Zealand","startDate":"2011-05","conditions":"Morbid Obesity","enrollment":106},{"nctId":"NCT00733083","phase":"NA","title":"A Comparative Study With Parenteral Oxycodone, Morphine and Dexamethasone in Postoperative Pain in Paediatric Patients","status":"UNKNOWN","sponsor":"University of Turku","startDate":"2008-09","conditions":"Post Tonsillectomy Pain","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["oral medication consisting of Oxycodonhydrochlorid"],"phase":"marketed","status":"active","brandName":"OxyNorm","genericName":"OxyNorm","companyName":"Kures, Inc.","companyId":"kures-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OxyNorm is an immediate-release oral formulation of oxycodone that binds to opioid receptors in the central nervous system to provide rapid pain relief. Used for Moderate to severe acute pain, Breakthrough pain in opioid-tolerant patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}